Literature DB >> 19522871

Uncovering symptom progression history from disease registry data with application to young cystic fibrosis patients.

Jun Yan1, Yu Cheng, Jason P Fine, Huichuan J Lai.   

Abstract

The growing availability of various disease registry data has brought precious opportunities to epidemiologists to understand the natural history of the registered diseases. It also presents challenges to the traditional data analysis techniques because of complicated censoring/truncation schemes and temporal dynamics of covariate influences. In a case study of the Cystic Fibrosis Foundation Patient Registry data, we propose analyses of progressive symptoms using temporal process regressions, as an alternative to the commonly employed proportional hazards models. Two endpoints are considered, the prevalence of ever positive and currently positive for Pseudomonas aeruginosa (PA) infection in the lungs, which capture different aspect of the disease process. The analysis of ever PA positive via a time-varying coefficient model demonstrates the lack of fit, as well as the potential loss of information, in the standard proportional hazards analysis. The analysis of currently PA positive yields results that are clinically meaningful and have not previously been reported in the cystic fibrosis literature. Our analyses demonstrate that prenatal/neonatal screening results in lower prevalence of PA infection compared to traditional diagnosis via signs and symptoms, but this benefit attenuates with age. Calendar years of diagnosis also affect the risk of PA infection; patients diagnosed in more recent cohort show higher prevalence of ever PA positive but lower prevalence of currently PA positive.

Entities:  

Mesh:

Year:  2009        PMID: 19522871      PMCID: PMC3640499          DOI: 10.1111/j.1541-0420.2009.01288.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  18 in total

1.  Nonparametric analysis of recurrent events and death.

Authors:  D Ghosh; D Y Lin
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

2.  Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality.

Authors:  M H Gail; L Kessler; D Midthune; S Scoppa
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

3.  Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years.

Authors:  Baroukh M Assael; Carlo Castellani; Marisol Barao Ocampo; Patrizia Iansa; Andrea Callegaro; Maria Grazia Valsecchi
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

4.  Estimation and projections of cancer prevalence from cancer registry data.

Authors:  Arduino Verdecchia; Giovanni De Angelis; Riccardo Capocaccia
Journal:  Stat Med       Date:  2002-11-30       Impact factor: 2.373

5.  Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.

Authors:  N H Valerius; C Koch; N Høiby
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

6.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Authors:  M R Kosorok; L Zeng; S E West; M J Rock; M L Splaingard; A Laxova; C G Green; J Collins; P M Farrell
Journal:  Pediatr Pulmonol       Date:  2001-10

7.  Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis.

Authors:  HuiChuan J Lai; Yu Cheng; Hyungjun Cho; Michael R Kosorok; Philip M Farrell
Journal:  Am J Epidemiol       Date:  2004-03-15       Impact factor: 4.897

8.  Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.

Authors:  Tim W R Lee; Keith G Brownlee; Miles Denton; James M Littlewood; Steven P Conway
Journal:  Pediatr Pulmonol       Date:  2004-02

9.  The age at onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis--prognostic significance.

Authors:  C Aebi; R Bracher; S Liechti-Gallati; H Tschäppeler; A Rüdeberg; R Kraemer
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

10.  Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis.

Authors:  Miriam M Treggiari; Margaret Rosenfeld; George Retsch-Bogart; Ron Gibson; Bonnie Ramsey
Journal:  Pediatr Pulmonol       Date:  2007-09
View more
  2 in total

1.  Quantile regression for doubly censored data.

Authors:  Shuang Ji; Limin Peng; Yu Cheng; HuiChuan Lai
Journal:  Biometrics       Date:  2011-09-27       Impact factor: 2.571

2.  Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.

Authors:  Wenjie Wang; Ming-Hui Chen; Sy Han Chiou; Hui-Chuan Lai; Xiaojing Wang; Jun Yan; Zhumin Zhang
Journal:  BMC Med Res Methodol       Date:  2016-09-17       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.